Agios Pharmaceuticals, Inc. - Common Stock - Mali Tablolar (NASDAQ:AGIO) | MetaTrader

Tam grafiği aç Full chart

Agios Pharmaceuticals, Inc. - Common Stock

Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.

Haberler

Agios: 'Sell' On Tebapivat Setback LR-MDS And Competitive PK Activator Drug Class (AGIO)

Why Is Agios Pharmaceuticals (AGIO) Up 8.6% Since Last Earnings Report?

Dell hisseleri piyasa öncesinde yükseldi; Gap ve Firefly Aerospace geriledi

Agios kan hastalığı için tebapivat geliştirmeyi durduruyor

Agios Pharmaceuticals hisseleri deneme aksaklığıyla düştü

AGIO's Pyrukynd Gets Approval for Thalassemia in Europe

AB talasemi tedavisinde mitapivat’ı onayladı

Agios Seeks FDA Nod to Expand Mitapivat Label in Sickle Cell Disease

Agios, Avrupa hematoloji kongresinde mitapivat verilerini sunacak

Agios orak hücreli anemi için mitapivat başvurusu yaptı

AGIO Beats on Q1 Earnings & Sales, Stock Up 13% on New Drug Momentum

Agios Pharmaceuticals, Inc. (AGIO) Q1 2026 Earnings Call Transcript